Login Get Started
Browse
Shares
Technology
Software & IT Services
Infosys
Infosys logo

INFY - Infosys Share News

$17.39 -0.3  -1.6%

Last Trade - 25/02/21

Sector
Technology
RiskRating
Balanced
Size
Large Cap
Style
High Flyer
Market Cap £52.52bn
Enterprise Value £50.61bn
Revenue £9.56bn
Position in Universe 161st / 6718
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions INFY Dividends
All News
All News Reuters News Company Announcements
NYSE ORDER IMBALANCE 117798.0 SHARES ON BUY SIDE
Thu 8:50pm News
BRIEF-India's Infosys Says To Add 300 American Workers In Pennsylvania - Statement
Thu 3:40pm News
NYSE ORDER IMBALANCE 232118.0 SHARES ON BUY SIDE
Wed 8:50pm News
GRAPHIC-Indian retail investors dabble in stocks directly, ditching mutual funds
Wed 10:34am News
NYSE ORDER IMBALANCE 68088.0 SHARES ON BUY SIDE
Tue 8:50pm News
NYSE ORDER IMBALANCE 182363.0 SHARES ON BUY SIDE
Mon 8:50pm News
NYSE ORDER IMBALANCE 230490.0 SHARES ON BUY SIDE
19th Feb News
NYSE ORDER IMBALANCE 142461.0 SHARES ON BUY SIDE
18th Feb News
NYSE ORDER IMBALANCE 73844.0 SHARES ON BUY SIDE
17th Feb News
NYSE ORDER IMBALANCE 161139.0 SHARES ON BUY SIDE
16th Feb News
NYSE ORDER IMBALANCE 132372.0 SHARES ON BUY SIDE
10th Feb News
NYSE ORDER IMBALANCE 180211.0 SHARES ON SELL SIDE
9th Feb News
NYSE ORDER IMBALANCE 121999.0 SHARES ON BUY SIDE
4th Feb News
NYSE ORDER IMBALANCE 97772.0 SHARES ON SELL SIDE
3rd Feb News
NYSE ORDER IMBALANCE 84282.0 SHARES ON SELL SIDE
2nd Feb News
Indian shares close at record highs on gains in financial, infra stocks
2nd Feb News
NYSE ORDER IMBALANCE 176118.0 SHARES ON BUY SIDE
1st Feb News
NYSE ORDER IMBALANCE 120419.0 SHARES ON BUY SIDE
29th Jan News
Indian shares end lower as pharma, IT stocks weigh ahead of federal budget
29th Jan News
NYSE ORDER IMBALANCE 115874.0 SHARES ON BUY SIDE
28th Jan News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.